MiMedX Group
eröffnet am 16.08.17 09:48:16 von
neuester Beitrag 01.05.24 16:50:11 von
neuester Beitrag 01.05.24 16:50:11 von
Beiträge: 35
ID: 1.259.427
ID: 1.259.427
Aufrufe heute: 0
Gesamt: 1.585
Gesamt: 1.585
Aktive User: 0
ISIN: US6024961012 · WKN: A0MS6X · Symbol: MDXG
7,8900
USD
-2,35 %
-0,1900 USD
Letzter Kurs 02:00:00 Nasdaq
Neuigkeiten
15.05.24 · globenewswire  |
30.04.24 · globenewswire |
16.04.24 · globenewswire |
27.03.24 · globenewswire |
Werte aus der Branche Gesundheitswesen
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,7400 | +73.900,00 | |
| 1,3200 | +23,36 | |
| 1,3850 | +15,42 | |
| 33,95 | +14,31 | |
| 24,020 | +13,52 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 2,3000 | -14,18 | |
| 3,4000 | -14,36 | |
| 0,5121 | -14,65 | |
| 1,0100 | -15,83 | |
| 3,2500 | -20,63 |
Beitrag zu dieser Diskussion schreiben
Feedback
Antwort auf Beitrag Nr.: 75.714.471 von Charly_2 am 01.05.24 16:48:02Mühsam ernährt sich das Eichhörnchen
https://finance.yahoo.com/news/q1-2024-mimedx-group-inc-1333…
Kursziel $12.50
Übernahme kommt früher!
https://finance.yahoo.com/news/q1-2024-mimedx-group-inc-1333…
Kursziel $12.50
Übernahme kommt früher!
Report ist da
https://finance.yahoo.com/news/mimedx-group-inc-mdxg-reports…
Up
Nachbörslich $8.80 +0.60 (+7.32%)
https://finance.yahoo.com/news/mimedx-group-inc-mdxg-reports…
Up
Nachbörslich $8.80 +0.60 (+7.32%)
Aktie marschiert
PROFITABLE! Beat, Beat and Raise. Third quarter 2023 net sales of $81.7 million, an increase of 20.7% over third quarter 2022, beating estimate of $78.1 million. GAAP net income of $8.5 million for third quarter 2023, beating estimate of $5 million. Sales guidance raised from mid to high teens to high teens.
Drückerkolonne sollte sich verpissen
Drückerkolonne sollte sich verpissen
Trading Spotlight
Antwort auf Beitrag Nr.: 74.243.853 von Charly_2 am 01.08.23 23:13:11Seit 1.1. +190.29%
Aktie legt zu
MIMEDX Announces Second Quarter 2023 Operating and Financial Results
MiMedx Group, Inc
Tue, August 1, 2023 at 10:01 PM GMT+2·15
MiMedx Group, Inc
Records Second Quarter Net Sales of $81.3 Million; an Increase of 21.5% Over the Prior Year Period
Increases Full-Year 2023 Guidance for Net Sales Growth
Welcomes Highly Successful MedTech Executive as Chief Financial Officer
Management to Host Conference Call on Tuesday, August 1, 2023, at 5:00 PM ET
MARIETTA, Ga., Aug. 01, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2023, which ended June 30, 2023, including net sales of $81.3 million, net income of $1.2 million and Adjusted EBITDA1 of $14.1 million.
MIMEDX Announces Second Quarter 2023 Operating and Financial Results
MiMedx Group, Inc
Tue, August 1, 2023 at 10:01 PM GMT+2·15
MiMedx Group, Inc
Records Second Quarter Net Sales of $81.3 Million; an Increase of 21.5% Over the Prior Year Period
Increases Full-Year 2023 Guidance for Net Sales Growth
Welcomes Highly Successful MedTech Executive as Chief Financial Officer
Management to Host Conference Call on Tuesday, August 1, 2023, at 5:00 PM ET
MARIETTA, Ga., Aug. 01, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2023, which ended June 30, 2023, including net sales of $81.3 million, net income of $1.2 million and Adjusted EBITDA1 of $14.1 million.
MDXG receives Notice of Allowance from US Patent Office for patent application 17/120,626 "Placental tissue grafts and improved methods of preparing and using the same"
Up 30% auf ~ 5 USD heute, 10 USD als Ziel
Up 30% auf ~ 5 USD heute, 10 USD als Ziel
Durchsuchen
